U.S. Markets closed

Exagen Inc. (XGN)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
2.4300-0.0600 (-2.41%)
At close: 04:00PM EST
2.3400 -0.09 (-3.70%)
After hours: 04:04PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close2.4900
Bid0.9700 x 800
Ask2.5700 x 1000
Day's Range2.3000 - 2.4900
52 Week Range2.1000 - 11.6900
Avg. Volume84,068
Market Cap39.279M
Beta (5Y Monthly)1.26
PE Ratio (TTM)N/A
EPS (TTM)-1.5610
Earnings DateNov 08, 2022 - Nov 14, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est12.25
  • Zacks

    Exagen Inc. (XGN) Reports Q3 Loss, Tops Revenue Estimates

    Exagen Inc. (XGN) delivered earnings and revenue surprises of 38.16% and 61.24%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    Exagen Inc. Reports Third Quarter 2022 Results

    Medicare Reimbursement ReturnsSAN DIEGO, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended September 30, 2022. Third Quarter Highlights: Total revenue of $14.7 million recognized in the third quarter of 2022. Our flagship AVISE® CTD test, including AVISE® Lupus, recognized revenue of $12.8 million in the third quarter of 2022.Delivered 35,569 AVISE CTD tests, including AVISE Lupu

  • GlobeNewswire

    Exagen Inc. to Participate in Fourth Quarter Investor Conferences

    SAN DIEGO, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced that management will participate in the following fourth quarter investor conferences. Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum Thursday, November 17, 2022, at the Westin NY Grand Central Hotel Cantor Fitzgerald Medical & Aesthetic Dermatology, Ophthalmology & MedTech Conference Panel Presentation - Diagnostics Tool Time: No